Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Novo Nordisks new oral GLP-1, Wegovy pill, is a once-daily pill offering comparable weight-loss results (an average of 13.6% of your body weight) to injectable Wegovy.^ ^Eligible patients lost an average of 13.6% of their body weight in a 64-week clinical trial evaluating 25 mg oral semaglutide compared to those on 2.4 mg injectable semaglutide who lost an average of 14.9% of their body weight in a 68-week clinical trial
To do this, your care provider will 1) review your medical history and 2) gauge your overall risk for heart attack or stroke
Someone with high GLP-1 receptor sensitivity may feel full after eating half their usual portion by day 3, while another person needs two weeks to notice meaningful change
Your needs might be different, so its best to ask your doctor whats right for you
We take time to explain the why behind your symptoms, helping you feel informed, empowered, and supported every step of the way
US$ 26.51
US$ 28.22
US$ 26.91
US$ 27.09
US$ 20.11
US$ 22.32
US$ 22.36
US$ 29.31
US$ 23.82
US$ 27.77
